Chiorescu S, Andercou OA, Grad NO, Mironiuc IA. Intraperitoneal Administration of Rosuvastatin Prevents Postoperative Peritoneal Adhesions by Decreasing the Release of Tumor Necrosis Factor. Medicine and Pharmacy Reports [Internet]. 30Jan.2018 [cited 17Jul.2024];91(1):79-4. Available from: https://ami.info.umfcluj.ro/medpharmareports/index.php/mpr/article/view/859